Zevtera, also known by its generic name ceftobiprole, is a broad-spectrum cephalosporin antibiotic designed for the treatment of a variety of bacterial infections. It is particularly effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), as well as Gram-negative bacteria, making it a valuable option in the fight against complicated skin and soft tissue infections, as well as pneumonia. Zevtera operates by disrupting the synthesis of the bacterial cell wall, leading to the death of the bacteria. Its broad-spectrum activity and efficacy against resistant strains of bacteria make it a critical tool in modern medicine for treating severe bacterial infections where other antibiotics may not be effective.